Typical Protocol: Common research protocols use a loading phase of roughly 4-8 mg per week (split into 2-3 subcutaneous injections) for 4-6 weeks, followed by a maintenance phase of about 2-6 mg biweekly for another 4-8 weeks, with a full cycle running 8-14 weeks and at least 4 weeks off before repeating
S.DingZ.GanemB.CreightonD
Avoid use of hydroxy acids at the same time as GHK products (use at opposite end of the day)
Formulated with benzyl alcohol, it supports multiple withdrawals from the same vial, making it more versatile than single-use sterile water options
Peptide therapy supports a wide range of goals including hormone balance, recovery, anti-aging, and immune optimization
Already training consistently before starting: Patients at our clinic in Doral who see the strongest lean mass response to CJC-1295/Ipamorelin are those who were already training 3 or more times per week before their first injection